MRNA ▾TradingViewOVTLYR consoleNews (1w)Earnings search — Moderna, Inc.

Healthcare · ETF XLV · as of 2026-09-18

Daily · EMA 10 / 20 / 50 · SMA 200 · VolPress: buy/sell split, 20-SMA, white dot = above avg · · E = earnings · RS vs SPY ⓘ · ● RS new high ⓘ
MRNA
Moderna, Inc. NMS
Healthcare · Biotechnology

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and ...

Market cap
25.1B
P/E (TTM)
-
EPS (TTM)
-
Employees
4,700
IPO
2018-12-07
Website
modernatx.com

Price & today

$154.04 ATR(14) 11.77 (7.64%)
Stock today-2.55%
Sector ETF today-0.25%
Residual (stock-specific)-2.30%

Sector correlation

20-day correlation with XLV0.56
60-day correlation with XLV0.48
Status normal

Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.

Technicals

10 EMA$146.90
20 EMA$137.30
50 EMA$110.46
EMA stackBULLISH
RSI(14)63.3
52-week high distance+158.67%
52-week low distance+591.38%

Signals

Market F&G46.9
Bull%12.2%
OVTLYR status BUY (2d)
Sector rank#454
Next earnings 2026-11-04 (BMO, 46d)
TradingView OVTLYR console More news (Google) Sector dashboard (XLV)

MarketSmith metrics - our compute

RS Rating
99.0
ADR%
8.3
RMV (tight)
59.0
Ext (ATR>20EMA)
1.4
Rel Vol
113.0%
U/D 50d
1.34
U/D 25d
1.46
Accum/Dist 25d
6 / 6
EPS YoY
+8.0%
LoD dist
32.0
Off 52w High
12.8%
Above 52w Low
591.4%
1W / 1M
+7.0 / -11.7
Avg $Vol 50d
2.44B
Mkt Cap (B)
61.1
Trend 8/8
YES
Leads Group
YES
Sector XLV
+1.8% 1W
Base len (VCP)
16wk (6/22)
Coil (base shape)
85TVPX
not available: float_shares(NULL->no Float%)
What do these abbreviations mean?
RS Rating
- IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
ADR%
- average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
RMV (tight)
- Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
Ext (ATR>20EMA)
- how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
Rel Vol
- latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
U/D 50d / 25d
- up-day vs down-day volume over the window. 1.1+ = net accumulation (institutions buying); under 0.9 on the 25d = net selling.
Accum/Dist 25d
- heavy-volume up days vs heavy-volume down days in the last 25 sessions (close moved 0.2%+ on above-average volume). The institutional-participation footprint; 5+ distribution days = O'Neil caution line.
LoD dist
- close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
Off/Above 52w
- trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
Trend 8/8
- all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP pivot.
Base len (VCP)
- weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.

Fundamentals & valuation - reference, not entry inputs

P/E (TTM)
-
Fwd P/E
-
PEG
-
Price/Book
-
Profit margin
-
ROE
-
Debt/Equity
-
Rev growth
-
Analyst target
$42 (-73%)
Analyst rating
UNDERPERFORM
Institutional %
76.5%
Insider %
-
Float %
-
Valuation and analyst figures are Yahoo company stats (weekly refresh, ~3,000 larger names - blanks are honest gaps); logo, employees, website and IPO date are Massive company reference. Momentum/VCP entries do not use valuation - this card is context so you do not have to leave the page.

Company data - context read, not entry inputs

Industry rank
57 / 147
Industry
Biotechnology
Float
-
Float turnover 20d
-
Avg $Vol 20d / 50d
3.24B / 2.44B
Days to cover
-
Short % float
-
Institutional %
76.5%
Weinstein stage
2
Float, short interest and institutional % come from Yahoo company stats, refreshed weekly for ~3,000 larger names - a blank means Yahoo does not publish the figure for this stock, not that it is zero. Dollar volume and float turnover are computed from our own price bars; industry rank from our rotation data; stage from the weekly chart.

Quarterly EPS - earnings acceleration

A dash in %Chg is deliberate: the year-ago figure was a loss, so a growth % would be meaningless. A dash in Sales means we have no revenue figure for that quarter - read it as a gap in our data, not as zero revenue.

QuarterEPS ($)%Chg YoYSales ($M)%Chg
Nov-24 0.03 - 1,862.0 +2%
Feb-25 -2.91 -629% 966.0 -66%
May-25 -2.52 - 108.0 -35%
Aug-25 -2.13 - 142.0 -41%
Nov-25 -0.51 - 1,016.0 -45%
Feb-26 -2.11 - 678.0 -30%
Apr-26 -3.40 - 389.0 +260%
Jul-26 -1.97 - 145.0 +2%
† = SEC carries this same fiscal quarter under a second period-end with a materially different figure (hover for it) - a restatement, merger recast or successor-period split; %Chg is blanked when the two are more than 15% apart. It fires only when the two period-ends DISAGREE, so it is a floor, not a guarantee that the rest of the column shares one basis · ‡ = the revenue concept changed from the previous quarter WITH A FIGURE (hover for both) - a blank row in between is skipped, as the eye does - a step at that row is a change of basis, not necessarily of business · EPS = Yahoo eps_actual (the figure MarketSmith/Deepvue show) - whether a given quarter is GAAP or excludes a one-off follows the filing, so it can sit either side of another vendor's number; AAPL's Oct-24 row, the Sep-2024 fiscal quarter, is $0.97 here - GAAP, including the EU tax charge - where TradingView's year implies $1.64 · Sales ($M) = SEC EDGAR quarterly revenue (fiscal Q4 derived as FY minus 9-mo) · quarter = report month · %Chg blank = prior-year base under $0.05 (not meaningful).

Recent news - our DB (Finnhub + OVTLYR)